Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19

by bizlift | Mar 26, 2020 | Portfolio News, Twist Press Releases

Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

by bizlift | Feb 24, 2020 | Portfolio News, Twist Press Releases

Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market

by bizlift | Jan 27, 2020 | Portfolio News, Twist Press Releases

Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery

by bizlift | Jan 15, 2020 | Portfolio News, Twist Press Releases

Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration

by bizlift | Dec 29, 2019 | Portfolio News, Twist Press Releases

GRAIL Appoints Gautam Kollu as Chief Commercial Officer

by bizlift | Dec 16, 2019 | Grail Press Releases, Portfolio News, Twist Press Releases